The NABLFA was developed for the analysis of blood samples from CRC patients, wherein four single nucleotide polymorphisms (SNPs) that matched the normal KRAS gene and three of the most common mutations in the KRAS gene correlating to CRC in synthetic DNA samples, cancer cells, and ctDNA were detected [103]. Here, KRAS is linked to colorectal carcinoma.